Symbol="LUMO"
AssetType="Common Stock"
Name="Lumos Pharma Inc"
Description="Lumos Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of rare disease therapies. The company is headquartered in Austin, Texas."
CIK="1126234"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="2503 SOUTH LOOP DRIVE, SUITE 5100, AMES, IA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="26717600"
EBITDA="-32298000"
PERatio="None"
PEGRatio="None"
BookValue="6.42"
DividendPerShare="0"
DividendYield="0"
EPS="-3.45"
RevenuePerShareTTM="0.252"
ProfitMargin="0"
OperatingMarginTTM="-15.38"
ReturnOnAssetsTTM="-0.258"
ReturnOnEquityTTM="-0.457"
RevenueTTM="2103000"
GrossProfitTTM="1523000"
DilutedEPSTTM="-3.45"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="5.22"
AnalystTargetPrice="18.33"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="22.45"
PriceToBookRatio="0.405"
EVToRevenue="1.11"
EVToEBITDA="1.564"
Beta="0.566"
num_52WeekHigh="9.56"
num_52WeekLow="2.95"
num_50DayMovingAverage="3.577"
num_200DayMovingAverage="4.394"
SharesOutstanding="8170500"
DividendDate="2020-03-19"
ExDividendDate="None"
symbol="LUMO"
open="3.31"
high="3.31"
low="3.10"
price="3.27"
volume="18911.00"
latest_trading_day="2023-07-24"
previous_close="3.22"
change="0.05"
change_percent="1.5528%"
aroon_positive_momentum_days="55"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="55"
Volume_recent_avg="19212"
Change_recent_avg="-0.01"
Delta_recent_avg="0.25"
Variance_recent_avg="0.12"
Change_ratio_recent_avg="-0.33"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="55"
Aroon_momentum_negative="45"
image_negative_thumbnail_id_1="490"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0115.jpeg"
image_negative_thumbnail_id_2="509"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0096.jpeg"
image_neutral_thumbnail_id_1="528"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0071.jpeg"
image_neutral_thumbnail_id_2="522"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0077.jpeg"
image_positive_thumbnail_id_1="965"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0127.jpeg"
image_positive_thumbnail_id_2="662"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0046.jpeg"
image_professor_thumbnail_id_1="1185"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0019.jpeg"
image_professor_thumbnail_id_2="1193"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0027.jpeg"
